Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed ruleComments close Jan. 19, 2027

Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Nov. 17, 2026. Document 2026-23351. Updated Nov. 18, 2026.

Read our story about this rule

Open for public comment until Jan. 19, 2027. Comment on Regulations.gov

What it does

The Food and Drug Administration (FDA or we) is proposing to issue a regulation finding that N-acetyl-L-cysteine (NAC) is not excluded from the dietary supplement definition in the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action, if finalized, would allow products containing NAC to be lawfully marketed as dietary supplements, provided that such products are not otherwise in violation of the FD&C Act. We also propose to provide that the addition of NAC to a dietary supplement is not a prohibited act under section 301(ll) of the FD&C Act.

The Food and Drug Administration's summary, as published in the Federal Register.

What it would change

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 190

Before this

No earlier Federal Register document under regulation identifier 0910-AI91 since Jan. 1, 2025.

What happens next and when

Either electronic or written comments on the proposed rule must be submitted by January 19, 2027.

The agency's dates, word for word.

Document number2026-23351
ActionProposed rule.
AgenciesHealth and Human Services Department; Food and Drug Administration
PublishedNov. 17, 2026
Comments closeJan. 19, 2027
Regulation identifier (RIN)0910-AI91
DocketFDA-2025-N-2699
Significant (marked in the Federal Register)Yes

Source: the Federal Register (public domain). The document in the Federal Register